Naltrexone Hydrochloride Tablets, USP, 50 mg, 100-count bottle, Rx only, MFG: Mallinckrodt Inc., NDC 0406-1170-03
Check against the official notice below — it lists the full affected range.
McKesson Medical-Surgical Inc. is recalling Naltrexone Hydrochloride Tablets, USP, 50 mg in 100-count bottles manufactured by Mallinckrodt Inc. The recall affects approximately 4 bottles containing 30 tablets per bottle that were distributed nationwide across the United States. The products are being recalled due to Current Good Manufacturing Practice (cGMP) deviations involving temperature abuse during storage or handling.
Because McKesson Medical-Surgical is unable to identify the specific lot numbers received by individual customers, affected consignees received individual letters containing the distribution date and the dates when impacted product may have been shipped to them. The recall notice does not specify a remedy or what action affected consumers should take.
Written by software from the official notice below. Not reviewed by a lawyer.
cGMP deviations: Temperature abuse
Reason for recall: cGMP deviations: Temperature abuse Distribution: USA nationwide. Quantity: 4 bottles/30 tablets per bottle Lot/code info: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.
Official record: FDA (Drug enforcement) ↗
Republished from the official source above; details can change — the source record controls.